Suzanne Kafaja

5.7k total citations
25 papers, 505 citations indexed

About

Suzanne Kafaja is a scholar working on Pathology and Forensic Medicine, Dermatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Suzanne Kafaja has authored 25 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 8 papers in Dermatology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Suzanne Kafaja's work include Systemic Sclerosis and Related Diseases (21 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers) and Dermatologic Treatments and Research (8 papers). Suzanne Kafaja is often cited by papers focused on Systemic Sclerosis and Related Diseases (21 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers) and Dermatologic Treatments and Research (8 papers). Suzanne Kafaja collaborates with scholars based in United States, Italy and Egypt. Suzanne Kafaja's co-authors include Dinesh Khanna, Daniel E. Furst, Philip J. Clements, Donald P. Tashkin, Michael D. Roth, Elizabeth R. Volkmann, Holly Wilhalme, Grace Hyun J. Kim, Chi‐Hong Tseng and Jonathan Goldin and has published in prestigious journals such as The Journal of Immunology, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Suzanne Kafaja

24 papers receiving 497 citations

Peers

Suzanne Kafaja
Suzanne Kafaja
Citations per year, relative to Suzanne Kafaja Suzanne Kafaja (= 1×) peers Nemanja Damjanov

Countries citing papers authored by Suzanne Kafaja

Since Specialization
Citations

This map shows the geographic impact of Suzanne Kafaja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Kafaja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Kafaja more than expected).

Fields of papers citing papers by Suzanne Kafaja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Kafaja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Kafaja. The network helps show where Suzanne Kafaja may publish in the future.

Co-authorship network of co-authors of Suzanne Kafaja

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Kafaja. A scholar is included among the top collaborators of Suzanne Kafaja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Kafaja. Suzanne Kafaja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
White, Barbara, Daniel E. Furst, Tracy Frech, et al.. (2025). Comparative Efficacy of Immunosuppressive Therapies in the Treatment of Diffuse Cutaneous Systemic Sclerosis. ACR Open Rheumatology. 7(3). e70004–e70004. 3 indexed citations
3.
Ladbury, Colton, Matthew Mei, Suzanne Kafaja, et al.. (2023). Autologous Stem Cell Transplantation With Intensity Modulated Total Body Irradiation Conditioning for Systemic Sclerosis. International Journal of Radiation Oncology*Biology*Physics. 116(5). 1019–1024.
4.
Chen, Yen T., Susan L. Murphy, Daniel E. Furst, et al.. (2023). Factors associated with life satisfaction in systemic sclerosis: Examining the moderating roles of social support and spiritual well-being. Journal of Scleroderma and Related Disorders. 8(2). 107–112. 2 indexed citations
5.
Khanna, Dinesh, Paul H. Caldron, Richard W. Martin, et al.. (2022). Adipose‐Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical Trial. Arthritis & Rheumatology. 74(8). 1399–1408. 20 indexed citations
6.
Spiera, Robert, Masataka Kuwana, Dinesh Khanna, et al.. (2021). OP0171 PHASE 3 TRIAL OF LENABASUM, A CB2 AGONIST, FOR THE TREATMENT OF DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC). Annals of the Rheumatic Diseases. 80. 102–103. 8 indexed citations
7.
Suliman, Yossra A., et al.. (2021). Responsiveness of the University of California Los Angeles Scleroderma Clinical Trial Consortium gastrointestinal tract 2.0 (UCLA-SCTC-GIT 2.0)to change in scleroderma patients. Journal of Scleroderma and Related Disorders. 6(3). 236–241. 2 indexed citations
8.
Suliman, Yossra A., Suzanne Kafaja, Gianluca Bagnato, et al.. (2020). Anti-vinculin antibodies in scleroderma (SSc): a potential link between autoimmunity and gastrointestinal system involvement in two SSc cohorts. Clinical Rheumatology. 40(6). 2277–2284. 14 indexed citations
9.
Barroso, Nashla, Thasia Woodworth, Daniel E. Fürst, et al.. (2019). The American English version of the validated French Flare Assessment in RA Questionnaire (FLARE-RA). Clinical Rheumatology. 39(1). 189–199. 3 indexed citations
10.
Suliman, Yossra A., Suzanne Kafaja, John FitzGerald, et al.. (2018). Ultrasound characterization of cutaneous ulcers in systemic sclerosis. Clinical Rheumatology. 37(6). 1555–1561. 32 indexed citations
11.
Kafaja, Suzanne, Isela Valera, Anagha Divekar, et al.. (2018). pDCs in lung and skin fibrosis in a bleomycin-induced model and patients with systemic sclerosis. JCI Insight. 3(9). 51 indexed citations
12.
Kafaja, Suzanne, Philip J. Clements, Holly Wilhalme, et al.. (2017). Reliability and Minimal Clinically Important Differences of FVC. Results from the Scleroderma Lung Studies (SLS-I and SLS-II). American Journal of Respiratory and Critical Care Medicine. 197(5). 644–652. 86 indexed citations
13.
Namas, Rajaie, Donald P. Tashkin, Daniel E. Furst, et al.. (2017). Efficacy of Mycophenolate Mofetil and Oral Cyclophosphamide on Skin Thickness: Post Hoc Analyses From Two Randomized Placebo‐Controlled Trials. Arthritis Care & Research. 70(3). 439–444. 60 indexed citations
14.
Suliman, Yossra A., Cosimo Bruni, Sindhu R. Johnson, et al.. (2017). Defining Skin Ulcers in Systemic Sclerosis: Systematic Literature Review and Proposed World Scleroderma Foundation (WSF) Definition. Journal of Scleroderma and Related Disorders. 2(2). 115–120. 53 indexed citations
15.
Kafaja, Suzanne & Philip J. Clements. (2016). Management of Widespread Skin Thickening in Diffuse Systemic Sclerosis. PubMed. 2(1). 49–60. 4 indexed citations
16.
Tashkin, Donald P., Elizabeth R. Volkmann, Chi‐Hong Tseng, et al.. (2016). Improved Cough and Cough-Specific Quality of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease. CHEST Journal. 151(4). 813–820. 51 indexed citations
17.
Valera, Isela, Suzanne Kafaja, Brandon Pham, Michael C. Fishbein, & Ram Raj Singh. (2016). Investigating mechanisms of sex bias in lung fibrosis using mice with sex chromosome complement. The Journal of Immunology. 196(1_Supplement). 197.8–197.8. 2 indexed citations
18.
Mills, Sarah D., Rina S. Fox, Erin L. Merz, et al.. (2015). Evaluation of the Satisfaction with Appearance Scale and Its Short Form in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life Study. The Journal of Rheumatology. 42(9). 1624–1630. 17 indexed citations
19.
Wallace, Beth, Suzanne Kafaja, Daniel E. Furst, et al.. (2015). Reliability, validity and responsiveness to change of the Saint George’s Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis. Lara D. Veeken. 54(8). 1369–1379. 19 indexed citations
20.
McAlindon, Timothy E., Eugene Y. Kissin, Levon N. Nazarian, et al.. (2012). American College of Rheumatology report on reasonable use of musculoskeletal ultrasonography in rheumatology clinical practice. Arthritis Care & Research. 64(11). 1625–1640. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026